In more advanced CKD, the influence of confounders, for example bone metabolism, is probably more important, which could explain partially that no significant associations were observed between PTH or FGF-23 and eGFR in CKD stage 4–5, while they were present in CKD stage 2–3 (table 4). Here, FGF23 is linked to chronic kidney disease.